Johnson & Johnson to buy Firefly Bio for $1 billion
Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published June 8, 2026 at 7:18 AM.